The E1 Protein of Human Papillomavirus Type 16 Is Dispensable for Maintenance Replication of the Viral Genome

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 3276-3283

  Egawa, Nagayasu ^a   Nakahara, Tomomi ^a   Ohno, Shin Ichi ^a   Narisawa Saito, Mako ^a   Yugawa, Takashi ^a   Fujita, Masatoshi ^a,b   Yamato, Kenji ^c   Natori, Yukikazu ^d   Kiyono, Tohru ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d RNAi Company Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA REPLICATION; EPISOME; GENE DELETION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION TERMINATION; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

CELL LINE; DNA REPLICATION; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 84857934131     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06450-11     Document Type: Article

References (45)

1. Angeletti PC, Kim K, Fernandes FJ, Lambert PF. 2002. Stable replication of papillomavirus genomes in Saccharomyces cerevisiae. J. Virol. 76:3350-3358.
2. Berg M, Stenlund A. 1997. Functional interactions between papillomavirus E1 and E2 proteins. J. Virol. 71:3853-3863.
3. Buchholz F, Angrand PO, Stewart AF. 1998. Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat. Biotechnol. 16:657-662.
4. Chiang CM, et al. 1992. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc. Natl. Acad. Sci. U. S. A. 89:5799-5803.
5. D'Abramo CM, Archambault J. 2011. Small molecule inhibitors of human papillomavirus protein-protein interactions. Open Virol. J. 5:80-95.
6. Del Vecchio AM, Romanczuk H, Howley PM, Baker CC. 1992. Transient replication of human papillomavirus DNAs. J. Virol. 66:5949-5958.
7. Doorbar J. 2006. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (Lond.) 110:525-541.
8. Egawa K. 2003. Do human papillomaviruses target epidermal stem cells? Dermatology 207:251-254.
9. Faucher AM, et al. 2004. Discovery of small-molecule inhibitors of the ATPase activity of human papillomavirus E1 helicase. J. Med. Chem. 47: 18-21.
10. Fradet-Turcotte A, et al. 2011. Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATMdependent DNA damage response. J. Virol. 85:8996-9012.
11. Frattini MG, Laimins LA. 1994. Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc. Natl. Acad. Sci. U. S. A. 91:12398-12402.
12. Hoffmann R, Hirt B, Bechtold V, Beard P, Raj K. 2006. Different modes of human papillomavirus DNA replication during maintenance. J. Virol. 80:4431-4439.
13. Jeon S, Lambert PF. 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 92:1654-1658.
14. Kanegae Y, et al. 1996. Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene 181:207-212.
15. Kasukawa H, Howley PM, Benson JD. 1998. A fifteen-amino-acid peptide inhibits human papillomavirus E1-E2 interaction and human papillomavirus DNA replication in vitro. J. Virol. 72:8166-8173.
16. Kim K, Angeletti PC, Hassebroek EC, Lambert PF. 2005. Identification of cis-acting elements that mediate the replication and maintenance of human papillomavirus type 16 genomes in Saccharomyces cerevisiae. J. Virol. 79:5933-5942.
17. Kim K, Lambert PF. 2002. E1 protein of bovine papillomavirus 1 is not required for the maintenance of viral plasmid DNA replication. Virology 293:10-14.
18. Lee JH, et al. 2004. Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism. Proc. Natl. Acad. Sci. U. S. A. 101:2094-2099.
19. Lindner SE, Sugden B. 2007. The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. Plasmid 58:1-12.
20. Lu JZ, Sun YN, Rose RC, Bonnez W, McCance DJ. 1993. Two E2 binding sites (E2BS) alone or one E2BS plus an A/T-rich region are minimal requirements for the replication of the human papillomavirus type 11 origin. J. Virol. 67:7131-7139.
21. Maglennon GA, McIntosh P, Doorbar J. 2011. Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression. Virology 414:153-163.
22. Maiorano D, Lemaitre JM, Mechali M. 2000. Stepwise regulated chromatin assembly of MCM2-7 proteins. J. Biol. Chem. 275:8426-8431.
23. Mungal S, Steinberg BM, Taichman LB. 1992. Replication of plasmidderived human papillomavirus type 11 DNA in cultured keratinocytes. J. Virol. 66:3220-3224.
24. Nakano M, Ishimura M, Chiba J, Kanegae Y, Saito I. 2001. DNA substrates influence the recombination efficiency mediated by FLP recombinase expressed in mammalian cells. Microbiol. Immunol. 45:657-665.
25. Nanbo A, Sugden A, Sugden B. 2007. The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. EMBO J. 26:4252-4262.
26. Narisawa-Saito M, et al. 2007. HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes. Oncogene 26:2988-2996.
27. Naviaux RK, Costanzi E, Haas M, Verma IM. 1996. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70:5701-5705.
28. Pittayakhajonwut D, Angeletti PC. 2008. Analysis of cis-elements that facilitate extrachromosomal persistence of human papillomavirus genomes. Virology 374:304-314.
29. Pittayakhajonwut D, Angeletti PC. 2010. Viral trans-factor independent replication of human papillomavirus genomes. Virol. J. 7:123.
30. Rabson MS, Yee C, Yang YC, Howley PM. 1986. Bovine papillomavirus type 1 3= early region transformation and plasmid maintenance functions. J. Virol. 60:626-634.
31. Rocque WJ, et al. 2000. Replication-associated activities of purified human papillomavirus type 11 E1 helicase. Protein Expr. Purif. 18:148-159.
32. Sakakibara N, Mitra R, McBride A. 2011. The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J. Virol. 85:8981-8995.
33. Sasaki R, et al. 2009. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes. Carcinogenesis 30:423-431.
34. Schmitt A, et al. 1996. The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J. Virol. 70: 1912-1922.
35. Sverdrup F, Khan SA. 1994. Replication of human papillomavirus (HPV) DNAs supported by the HPV type 18 E1 and E2 proteins. J. Virol. 68:505-509.
36. Takata Y, Kondo S, Goda N, Kanegae Y, Saito I. 2011. Comparison of efficiency between FLPe and Cre for recombinase-mediated cassette exchange in vitro and in adenovirus vector production. Genes Cells 16:765-777.
37. Ustav M, Stenlund A. 1991. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 10:449-457.
38. Ustav M, Ustav E, Szymanski P, Stenlund A. 1991. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J. 10:4321-4329.
39. Wang HK, Duffy AA, Broker TR, Chow LT. 2009. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 23:181-194.
40. White PW, Faucher AM, Goudreau N. 2011. Small molecule inhibitors of the human papillomavirus E1-E2 interaction. Curr. Top. Microbiol. Immunol. 348:61-88.
41. White PW, et al. 2005. Biphenylsulfonacetic acid inhibitors of the human papillomavirus type 6 E1 helicase inhibit ATP hydrolysis by an allosteric mechanism involving tyrosine 486. Antimicrob. Agents Chemother. 49: 4834-4842.
42. White PW, et al. 2003. Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction. J. Biol. Chem. 278:26765-26772.
43. Yang L, Li R, Mohr IJ, Clark R, Botchan MR. 1991. Activation of BPV-1 replication in vitro by the transcription factor E2. Nature 353:628-632.
44. Yates JL, Guan N. 1991. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol. 65:483-488.
45. Zur Hausen H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.